JapanStake
Pharmaceutical · Fiscal year end Jul 31

StemRIM Inc.

4599

株式会社ステムリム

FIGI BBG00PNKK6G14599.T4599 JPCorp. no. 6120901018131

Latest half-year results

First half · fiscal year to 2026-07 · filed 2026-03-12

For the first half of the fiscal year to 2026-07: Ordinary income ¥-1 billion, Net income ¥-0.9 billion.

This periodYear on year
Ordinary profit−¥958m—
Net profit to owners−¥929m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/4599/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2026-07-31
Revenue
—
Net income
−¥1.9bn
ROE
—
Equity ratio
70.4%
Dividend / share
—
Employees
48
Revenue · ¥bn
FY2022: ¥0.0bn 0.02 FY2022FY2023: ¥2.4bn 2.35 FY2023FY2024FY2025FY2026
Net income · ¥bn
FY2022: −¥1.9bn -1.95 FY2022FY2023: ¥0.2bn 0.17 FY2023FY2024: −¥2.0bn -2.02 FY2024FY2025: −¥1.9bn -1.93 FY2025FY2026: −¥1.9bn -1.85 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-07-31—−¥1.9bn¥5.9bn¥5.7bn—¥-29.63−¥1.6bn
2025-07-31—−¥1.9bn¥7.5bn¥7.3bn—¥-31.16−¥1.4bn
2024-07-31—−¥2.0bn¥9.1bn¥8.9bn—¥-32.98−¥1.9bn
2023-07-31¥2.4bn¥0.2bn¥10.7bn¥10.4bn1.9%¥2.8¥1.1bn
2022-07-31¥0.0bn−¥1.9bn¥9.6bn¥9.4bn—¥-32.92−¥1.4bn

Indicators

Computed by us from filings · fiscal year to 2026-07-31
MetricValuePercentile among listed companies
ROE, %——
Ordinary margin——
Equity ratio, %70.475.3
Revenue growth——
Net income growth0.040440.1
Operating cash flow / assets-0.27241.8
Policy-uncertainty measure0.38 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Regulation 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change −2.40pt in 90 days; 7.7% held by other listed companies.

Results wording balance: +0.33. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4599/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-10-27: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-10-28 · 取締役5名選任の件 · passed. /v1/companies/4599/voting

Ownership changes

All companies →
  • 2026-08-27
    Decrease−1.20pt

    individual filer reduced holdings in StemRIM Inc. (4599) to 5.52% from 6.72%.

    01020304050
    S100YYH9Original filing (PDF, Japanese)
  • 2026-08-20
    Decrease−1.20pt

    individual filer reduced holdings in StemRIM Inc. (4599) to 6.72% from 7.92%.

    01020304050
    S100YXRXOriginal filing (PDF, Japanese)
  • 2026-07-21
    Decrease−1.00pt

    individual filer reduced holdings in StemRIM Inc. (4599) to 7.92% from 8.92%.

    01020304050
    S100YRDUOriginal filing (PDF, Japanese)
  • 2026-07-07
    Decrease−1.04pt

    individual filer reduced holdings in StemRIM Inc. (4599) to 8.92% from 9.96%.

    01020304050
    S100YNE7Original filing (PDF, Japanese)
  • 2024-06-14
    Increase+1.12pt

    individual filer raised holdings in StemRIM Inc. (4599) to 7.32% from 6.20%.

    01020304050
    S100TLINOriginal filing (PDF, Japanese)
  • 2023-10-24
    Decrease−0.20pt

    individual filer reduced holdings in StemRIM Inc. (4599) to 9.96% from 10.16%.

    01020304050
    S100S1HNOriginal filing (PDF, Japanese)
  • 2023-10-24
    Threshold

    Holdings of individual filer in StemRIM Inc. (4599) moved below 10% (10.16% -> 9.96%).

    01020304050
    S100S1HNOriginal filing (PDF, Japanese)
  • 2023-05-26
    Decrease−0.19pt

    individual filer reduced holdings in StemRIM Inc. (4599) to 10.16% from 10.35%.

    01020304050
    S100QTQZOriginal filing (PDF, Japanese)
  • 2023-05-16
    Amendment−2.89pt

    individual filer filed a correction to a 5% report on StemRIM Inc. (4599).

    S100QRVJOriginal filing (PDF, Japanese)
  • 2023-05-08
    Amendment−2.89pt

    individual filer filed a correction to a 5% report on StemRIM Inc. (4599).

    S100QOUTOriginal filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥297¥718¥1,139 2022-09-022026-06-22 2026-06-22 · sold 50,000 @ ¥297 · individual filer2023-05-24 · sold 80,200 @ ¥1,118 · individual filer2023-05-23 · sold 56,400 @ ¥1,139 · individual filer2023-05-22 · sold 29,500 @ ¥1,128 · individual filer2023-05-19 · sold 32,400 @ ¥1,139 · individual filer2022-09-02 · bought 6,700 @ ¥1,045 · individual filer
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2023-05-19 – 2026-08-20-2,967,300−4.42pt¥1,128.88¥1,118–1,139
individual filer2026-06-19 – 2026-07-07-292,000−0.42pt¥297¥297–297
individual filer2022-08-04 – 2024-06-10+884,500+1.48pt¥1,045¥1,045–1,045

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4599/trades.

5% filings

Large shareholding reports on 4599
FiledFilerStakeChangeStated purpose
2026-08-27individual filer5.52%−1.20pt—
2026-08-20individual filer6.72%−1.20pt—
2026-07-21individual filer7.92%−1.00pt—
2026-07-07individual filer8.92%−1.04pt—
2024-06-14individual filer7.32%+1.12ptpure investment
2023-10-24individual filer9.96%−0.20pt—
2023-05-26individual filer10.16%−0.19pt—
2023-05-16individual filer16.82%−2.89pt—
2023-05-08individual filer16.82%−2.89pt—
2023-05-02individual filer16.82%−2.89pt—

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
2

Held by: Shionogi & Co.,Ltd. 4507, M3, Inc. 2413

Purposes, all holdings and mutual flags via /v1/companies/4599/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-07-31
ShareholderSharesRatio
individual holder9,980,00015.90%
individual holder5,400,0008.60%
塩野義製薬株式会社4,650,0007.40%
individual holder3,830,0006.10%
individual holder3,650,0005.80%
individual holder2,370,0003.80%
みやこ京大イノベーション投資事業有限責任組合1,943,0003.10%
individual holder1,538,0002.50%
individual holder1,088,0001.70%
株式会社ＳＢＩ証券911,0001.50%

U.S. funds holding 4599

SEC Form N-PORT, reports to 2026-07-31

1 U.S. funds held 43,600 shares worth $0.1m.

FundSharesValue% of fundAs of
iShares International Small-Cap Equity Factor ETF
iShares Trust
43,600$0.1m0.012%2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4599
GET /v1/companies/4599/financials
GET /v1/companies/4599/details
GET /v1/companies/4599/segments
GET /v1/companies/4599/voting
GET /v1/companies/4599/tender-offers
GET /v1/companies/4599/indicators
GET /v1/companies/4599/earnings-releases
GET /v1/events?ticker=4599
GET /v1/companies/4599/trades         
GET /v1/companies/4599/cross-holdings 
GET /v1/companies/4599/brief

Plans from $9 a month · Documentation